Signum Biosciences Inc

Signum Biosciences Inc. is a private biotechnology company based in Princeton, New Jersey. The company employs 18 people and generates an annual revenue of $5 million. Signum Biosciences focuses on developing small-molecule therapeutics derived from its phosphatase platform to address signal transduction imbalances. Their technology aims to create novel pharmaceutical therapeutics by targeting and modulating key components of cellular signaling networks, such as G-Protein-Mediated membrane receptor signaling and Protein phosphorylation. The company has developed a strong intellectual property portfolio in the field of Signal Transduction Modulators (STMs). These STMs, including G-Protein modulators (GPMs) and Phospho-Protein modulators (PPMs), have applications in pharmaceuticals and can also be used in cosmetics and dietary supplements to mitigate health and well-being issues stemming from cellular stress. For more information about Signum Biosciences Inc., please visit their website at signumbiosciences.com.